NEW YORK, July 13, 2020 - Arsenal Capital Partners (“Arsenal”), a leading private equity firm that invests in specialty industrials and healthcare companies, today announced several significant human capital updates.
Pharma Value Demonstration, a portfolio company of Arsenal, reached an agreement with the board of Cello Health plc on the terms of a recommended cash offer for the entire issued, and to be issued, share capital of Cello.
Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced today the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
An investor group led by Leonard Green & Partners, L.P., in partnership with Arsenal Capital Partners and Novo Holdings, today announced that they have agreed to terms on a recapitalization of WCG. The recapitalization was structured to enhance the resources with which WCG will continue to extend its position as the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. Financial terms of the transaction were not disclosed.
Arsenal Capital Partners, a leading specialized private equity firm investing in specialty industrials and healthcare companies, announced today the addition of Michael Bernstein to its healthcare team.
